Smoking status is associated with serum high molecular adiponectin levels in community-dwelling japanese men

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 4, 2010, Pages 423-430

  Kawamoto, Ryuichi ^a,b   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Ohtsuka, Nobuyuki ^b   Kusunoki, Tomo ^a,b   Abe, Masanori ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

Adiponectin; Body mass index; Insulin resistance; Risk factor; Smoking

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMMUNITY LIVING; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPANESE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77953514768     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.3681     Document Type: Article

References (29)

1. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distri-bution, insulin sensitivity and plasma lipoproteins: evi-dence for independent roles of age and sex. Diabetologia, 2003; 46: 459-469
2. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 dia-betic patients. Arterioscler Thromb Vasc Biol, 2000; 20: 1595-1599
3. Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, Wang Y: Adiponectin, an unlocking adipocytokine. Cardiovasc Ther, 2009; 27: 59-75
4. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multimerization of human adipo-nectin mutants associated with diabetes. Molecular struc-ture and multimer formation of adiponectin. J Biol Chem, 2003; 278: 40352-40363
5. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 2006; 29: 1357-1362
6. Seino Y, Hirose H, Saito I, Itoh H: High molecular weight multimer form of adiponectin as a useful marker to evalu-ate insulin resistance and metabolic syndrome in Japanese men. Metabolism, 2007; 56: 1493-1499
7. Tabara Y, Osawa H, Kawamoto R, Tachibana-Iimori R, Yamamoto M, Nakura J, Miki T, Makino H, Kohara K: Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk fac-tors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab, 2008; 93: 715-722. 2007
8. Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi N, Ohashi K, Kihara S, Funahashi T, Rakugi H, Ogihara T: Association of hypoadiponec-tinemia with smoking habit in men. Hypertension, 2005; 45: 1094-1100
9. Hodge AM, Westerman RA, de Courten MP, Collier GR, Zimmet PZ, Alberti KG: Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord, 1997; 21: 50-53
10. Takefuji S, Yatsuya H, Tamakoshi K, Otsuka R, Wada K, Matsushita K, Sugiura K, Hotta Y, Mitsuhashi H, Oiso Y, Toyoshima H: Smoking status and adiponectin in healthy Japanese men and women. Prev Med, 2007; 45: 471-475
11. Tsukinoki R, Morimoto K, Nakayama K: Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis, 2005; 4: 27-34
12. Sull JW, Kim HJ, Yun JE, Park EJ, Kim G, Jee SH: Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J, 2009; 56: 73-78
13. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabe-tologia, 1985; 28: 412-419
15. The Japanese Society of Nephrology: Japanese version of GFR estimation. http://www.jsn.or.jp, 2007; Updated Oct 29
16. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension, 2004; 43: 1318-1323
17. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab, 2002; 87: 2764-2769
18. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obe-sity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001; 86: 1930-1935
19. Lin J, Hu FB, Curhan G: Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care, 2007; 30: 239-244
20. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinedio-nes on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes, 2002; 51: 2968-2974
21. Henry RR: Thiazolidinediones. Endocrinol Metab Clin North Am, 1997; 26: 553-573
22. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K: Blockade of the renin-angiotensin system increases adiponectin con-centrations in patients with essential hypertension. Hyper-tension, 2003; 42: 76-81
23. Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Cho H, Lee JH: Plasma adiponectin is related to other cardio-vascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis. Clin Chim Acta, 2006; 370: 63-71
24. Ambrose JA, Barua RS: The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol, 2004; 43: 1731-1737
25. Armani C, Landini L Jr, Leone A: Molecular and bio-chemical changes of the cardiovascular system due to smoking exposure. Curr Pharm Des, 2009; 15: 1038-1053
26. Fröhlich M, Sund M, Löwel H, Imhof A, Hoffmeister A, Koenig W: Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J, 2003; 24: 1365-1372
27. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, Dells-perger KC, Zhang C: Role of TNF-alpha in vascular dys-function. Clin Sci, 2009; 116: 219-230
28. Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S: C-reac-tive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol, 2006; 26: 2476-2482
29. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimo-mura I, Matsuzawa Y: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001; 50: 2094-2099